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Background: The aim of this study was to evaluate the cardioprotective effects 
of aqueous fraction of Marrubium vulgare hydroalcoholic extract on cardiac pa-
rameters in ischaemic-reperfused isolated rat hearts. 
Materials and methods: The aerial parts of the plant were extracted with metha-
nol 70% by maceration. The water-soluble portion of the total hydroalcoholic 
extract was prepared with liquid-liquid extraction (LLE). Afterwards, the antioxi-
dant activity, total phenolic and flavonoids content of the aqueous fraction were 
determined. In order to evaluate the effects of the aqueous fraction on cardiac 
parameters and ischaemia-reperfusion (I/R) injury, the Langendroff method was 
used on male Wistar rats. Harvested hearts were cannulated immediately to the 
Langendroff apparatus and subjected into 30 min regional ischaemia and 2 h 
reperfusion, either by a modified Krebs-Henseleit buffer (KHB) solution or enriched 
KHB solution with plant extract (10, 20, 40 µg/mL). 
Results: The aqueous fraction was found to be a scavenger of DPPH radical 
with RC50 value of 47 µg/mL. The total phenolic and flavonoids content of the 
fraction was 6.05 g gallic acid equivalent and 36.13 mg quercetin equivalent per 
100 g of dry plant material. In addition, 40 µg/mL of Marrubium vulgare aqueous 
fraction significantly decreased infarct size in comparison to control group. All 
doses considerably reduced the total ventricular ectopic beats during 30 min of 
ischaemia. The extract at dose of 40 µg/mL noticeably decreased the arrhythmias 
during the first 30 min of reperfusion. 
Conclusions: The results of the study indicated aqueous fraction of Marrubium 
vulgare possesses a protective effect against I/R injuries in isolated rat hearts. (Folia 
Morphol 2017; 76, 3: 361–371)
Key words: Marrubium vulgare, ischaemia-reperfusion (I/R) injury, 
Langendroff, ventricular ectopic beats, arrhythmias
INTRODUCTION
Ischaemia-reperfusion (I/R) injury is one of the 
important life-threaten medical problems world-
wide. In recent years, various experiments and clinical 
studies have been conducted to introduce effective 
natural compounds which can improve the function 
of the affected tissues or decrease the detrimental 
consequences of I/R injury [18, 29]. In ischaemia by 
Address for correspondence: Prof. F. Fathiazad, Department of Pharmacognosy, Tabriz University of Medical Sciences, Tabriz, Iran,  
tel: +984133372253, fax: +98413334798, e-mail: fathiazad@yahoo.com; fathiazad@tbzmed.ac.ir
362
Folia Morphol., 2017, Vol. 76, No. 3
circulatory arrest, the aerobic metabolism turns into 
anaerobic due to the imbalance between oxygen 
demand and supply. The anaerobic metabolism leads 
to the reduction of intracellular pH which results in 
ionic homeostasis disturbances. Although a well-
timed reperfusion is fundamental for recovery of 
a dying myocardium but by sudden restoration of blood 
flow to the ischaemic myocardium, a burst of reactive 
oxygen species (ROS) will be produced as a reaction to 
hyperoxia which can make the situation worse. This 
phenomenon is known as myocardial I/R injury [1].
The overproduction of ROS not only influences 
the process of injury directly but also exacerbates the 
circumstance indirectly. ROS can initiate the oxidation 
of lipids in cell membrane, oxidation of proteins and 
cause DNA fragmentation (directly) whereas these 
species can intensify the ionic derangement i.e. Ca2+ 
overload in cytosol and induce the inflammatory 
factors (indirectly). As a result, the myocytes death 
occurs and myocardium loses its ability to function 
well [6, 26]. 
Marrubium vulgare L., known as horehound, is 
a medicinal herb from Lamiaceae family which mainly 
grows in North Africa, Central and Western Asia and 
also in some parts of Europe [19]. This perennial 
plant is widely distributed in northern and eastern 
provinces of Iran [10, 27]. M. vulgare is a popular 
medicinal herb and in traditional medicine has been 
used as a neurosedative, hypotensive, antispasmodic, 
antinociceptive, antidiabetic and anti-inflammatory 
agent. Studies dealing with the biological activities 
on the plants of Marrubium genus, revealed anti-
coagulant, anti-inflammatory, immunomodulating, 
cytotoxicity, vasorelaxant, hepatoprotective, hypolipi-
daemic, hypoglycaemic and antioxidant properties 
[4, 5]. The merit of the traditional use of M. vulgare 
along with its reported biological activities have 
been supported by the isolation and identification of 
a group of biologically active phytochemicals such 
as diterpenes, flavonoids, phenylpropanoid esters, 
tannins and sterols. Detailed phytochemical screening 
of M. vulgare showed that the plant is rich in mar-
rubiin diterpene, flavonoid compounds such as lu-
teolin, apigenin, quercetin, isoquercitrin, chrysoeriol, 
vitexin and polyphenols such as proanthocyanidins 
(Condensed tannins) [2, 20, 21, 24, 25]. Phenylpro-
panoids, a group of phenolics, were mostly detected 
in M. vulgare including acteoside, forsythoside B, 
arenarioside, ballotetroside, marruboside, and acethyl 
marruboside. Among them, acteoside, also known 
verbascoside, is the principle phenylpropanoid that 
is believed to be one of the key bioactive compound 
and responsible for many health benefits of the plant. 
Proanthocyanidins, the water-soluble subclass of the 
phenolic group, are composed of flavanol (catechins) 
units and rich in green tea, red wine, grape seeds and 
fruits like blueberries, strawberries, red apple and 
in nuts such as hazelnut and pistachio [1, 12, 22]. 
Catechin and epicatechin are the two most studied 
compounds from proanthocyanidins. Many studies 
have been done in order to prove that catechins play 
an important role in cure of myocardial ischaemia and 
reduce the mortality risk of cancer, myoglobinuric 
acute renal failure and congestive heart failure due 
to antioxidant, anti-inflammatory, and vasodilatory 
effects [12, 16]. These components give the plant 
superior antioxidant content. Hence, M. vulgare has 
potential in promotion of health and prevention of 
conditions associated with inflammation, cardiovas-
cular disease, dyslipidaemia, cancer, hyperglycaemia 
or increased oxidative stress. In this paper, concerning 
the polyephenols role in scavenging free radicals and 
with inspiration from Yousefi et al. [27] study which 
showed the cardioprotective effect of methanoilc 
extract of M. vulgare, it has been decided to evaluate 
whether the aqueous extract of M. vulgare has the 
cardioprotective effect against myocardial I/R injury.
MATERIALS AND METHODS
Solvents and chemicals
Methanol, ethyl acetate, chloroform, petroleum 
ether and the Krebs-Henseleit buffer (KHB) solution 
ingredients (potassium dihydrogen phosphate, potas-
sium chloride, magnesium chloride, sodium chloride, 
D-glucose, calcium chloride and sodium bicarbonate) 
all from Merck company (Germany) were used. Keta-
mine and xylazine were from Alfasan, Netherlands. 
Evans blue from Sigma, Japan and the triphenyl tetra-
zolium chloride (TTC) from Baker (England) were used. 
2,2-diphenyl-1-picrylhydrazyl (DPPH), Folin-Ciocalteu 
reagent and aluminium chloride all from Sigma Al-
drich chemical company (USA) were used. All other 
reagents and chemicals were of analytical grade.
Animals
Healthy male albino Wistar rats (270–300 g) were 
used in this study. They were housed in the standard 
cages, under a 12 h light/dark cycle. The animals 
were given food and water freely. The present study 
was done regarding the Guide for the Care and Use 
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of Laboratory Animals of Tabriz University of Medical 
Sciences, Tabriz, Iran.
Extract preparation 
The aerial parts of M. vulgare were collected dur-
ing flowering stage from Kiasar, Mazandaran prov-
ince, Iran. The air-dried plant materials (500 g) were 
grounded and powdered finely and then defatted 
by petroleum ether (2 L × 2) at 25°C. Afterwards, 
the plant materials were extracted with methanol 
70% by maceration (2 L × 4) at room temperature 
and the solvent was removed at 40°C using rotary 
evaporator. Subsequently, the water-soluble portion 
of the total hydroalcoholic extract was prepared after 
removing the non-polar fractions through liquid-
-liquid extraction (LLE) with chloroform and ethyl 
acetate, respectively. The water of resultant aqueous 
extract containing polar compounds was dried under 
reduced pressure, and the dried extract was kept in 
the refrigerator until the phytochemical analyses and 
pharmacological procedure.
DPPH radical scavenging assay 
This assay was performed using the method pro-
posed by Hamedeyazdan et al. [10]. 2, 2-diphenyl-
-1-picrylhydrazyl, known as DPPH, is a reagent which 
is used in laboratory assays in order to determine the 
antioxidant capacity of different samples, especially 
the herbal extracts. It composes of free radical mol-
ecules that make the colour of a solution purple and 
by neutralisation the colour turns into pale yellow. 
The stock concentration 1000 µg/mL of the aqueous 
fraction of the M. vulgare extract was prepared and 
then diluted with methanol to the concentrations 
below: 500, 250, 125, 62.5, 31.25 and 15.62 µg/mL.
All these concentrations were prepared in the vol-
ume of 2 mL. The same volume (2 mL) of 0.004% of 
DPPH solution was added to each tube. After 30 min 
incubation in 25°C, the absorbance was read against 
blank at 517 nm. Tests were carried out in triplicate 
where the average absorption was reported for each 
concentration. This test was done with quercetin as 
the positive control. The free radical scavenging of 
the extract was calculated in percent by the equa-
tion below: 
R% = [(Ablank – Asample) / Ablank] × 100 
where Ablank is the absorbance of the solvent (contain-
ing all reagents except the plant extract) and Asample 
is the absorbance of the sample. RC50 is the concen-
tration of the plant extract reducing 50% of the free 
radicals which was calculated from the graph of R% 
against aqueous extract concentrations in µg/mL.
Total phenolic content assay 
This assay was done through Folin-Ciocalteau 
method in order to determine the total phenol values 
[10]. 0.5 mL of aqueous fraction of M. vulgare solu-
tion were mixed with 5 mL Folin-Ciocalteau reagent 
(diluted in distilled water 1:10). After 5 min, 4 mL of 
Na2CO3 1 M was added to the mixture and shaken 
well. Following the incubation of the mixture at room 
temperature for about 15 min, the absorbance was 
measured by UV–VIS spectrophotometer at 765 nm. 
The standard curve was prepared by 50–250 µg/mL 
solutions of gallic acid in methanol: water (50:50) 
against the absorbance. The total phenolic content 
of the aqueous fraction was expressed as gallic acid 
equivalents, in mg/100 g of dry plant material.
Total flavonoids content assay 
In order to determine the total flavonoids con-
tent in M. vulgare aqueous fraction, the colori-
metric aluminium chloride method was performed 
[10]. 0.5 mL of the aqueous fraction with 1.5 mL 
methanol, 0.1 mL AlCl3 10%, 0.1 mL potassium 
acetate 1 M and 2.8 mL distilled water were mixed 
and shaken well. The mixture was allowed to stand 
at room temperature for 30 min, later the absorb-
ance of the mixture was measured by UV–VIS spec-
trophotometer at 415 nm.
The calibration curve was drawn by 31.25–250 
µg/mL of quercetin solutions in methanol. The value 
of total flavonoids was reported in mg per 100 g 
of dry plant material which was equivalent to 
quercetin.
Nitric oxide radical inhibition assay 
This assay was done according to Griess Illosvoy 
reaction. The reaction mixtures (3 mL) containing so-
dium nitroprusside (10 mM, 2 mL), phosphate buffer 
(pH: 7.4, 0.5 mL) and different concentrations of 
M. vulgare aqueous fraction (0.5 mL) were incubated 
at room temperature for 150 min, then 1 mL of 
sulphanilic acid reagent (0.33% in glacial acetic acid 
20%) was added to 0.5 mL of each reaction mixture. 
After being left for 5 min, 1 mL of naphthyl ethyl-
ene diamine dihydrochloride as a Griess reagent was 
added and they were allowed to stand for 30 min at 
25°C. Afterward, absorbances of the mixtures were 
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measured by UV–VIS spectrophotometer at 540 nm. 
Quercetin was used as the positive control [23]. The 
nitric oxide radical scavenging of the aqueous frac-
tion was calculated in percent by the equation below:
R% = [(Ablank – Asample) / Ablank] × 100
where Ablank is the absorbance of the solvent (con-
taining all reagents except the plant extract), Asample 
is the absorbance of the sample and R% represents 
the reduction percent. RC50 is the concentration of 
the plant extract reducing 50% of nitric oxide radicals 
which was calculated from the graph of R% against 
different concentrations of M. vulgare aqueous ex-
tract in µg/mL.
TLC analysis
To determine the presence of acteoside, the 
main phenylpropanoid, and bioactive compound in 
M. vulgare aqueous extract, the extract was subjected 
to qualitative thin layer chromatography (TLC) using 
pure acteoside as standard, solvent system chloro-
form: methanol: water (60:40:8) and stationary phase 
silicagel GF254 (Merck). The spot of acteoside was 
visualised by irradiation the TLC plate with ultraviolet 
light and spraying Alcl3 5% reagent.
Qualitative Stiasny assay
The aqueous extract (10 mL) was mixed with mix-
ture of hydrochloric acid and formaldehyde (1:2, 
5 mL) and allowed to be heated under reflux for 
30 min. The red-brown precipitation is a sign of cat-
echins presence [8].
The pharmacological procedure 
Male Wistar rats (270–300 g) were subjected into 
four groups (n = 6). Group number one is the control 
group that was perfused by KHB solution. The second, 
the third and the fourth groups were received KHB 
solution with different concentrations of aqueous 
fraction (10, 20 and 40 µg/mL, respectively) 5 min 
before ischaemia induction.
The rats were heparinised and anesthetised with 
the mixture of ketamine and xylazine. From the mo-
ment that the hearts were cannulated to the constant-
pressure Langendorff system (within the KHB solution 
circulation which was oxygenated by 95% O2/5% CO2 
and with the 80 mm Hg pressure and the tempera-
ture of 37°C) until the ischaemia induction time, was 
a period of 20 min which is called stabilisation phase. 
During this period, the hearts which were not follow-
ing a stable steady-state pattern were rejected. In the 
treated groups, 5 min before the end of the stabilisa-
tion phase, the hearts were perfused by M. vulgare 
aqueous fraction until the end of the reperfusion 
phase. Ischaemic phase started right after the stabili-
sation period. It was induced by occluding of left an-
terior descending coronary artery (LAD) via two plastic 
pipette tips which is known as regional ischaemia and 
lasted for 30 min. By removing these plastic tips after 
30 min of ischaemia, the reperfusion phase began. 
This phase continued for 120 min and after that the 
suture around the LAD was tied (knot) and then the 
hearts were ready for Evans blue staining which was 
perfused via the aortic cannula [3].
Hemodynamic changes record 
After mounting the heart on the Langendorff appara-
tus, a latex balloon connected to pressure transducer 
was inserted into the left ventricle in order to meas-
ure the left ventricular systolic and diastolic pressure 
(LVSP and LVDP, respectively), develop pressure (DP) 
and heart rate (HR) [3, 23]. Left ventricular developed 
pressure = LVSP – LVDP. The output volumes of KHB 
solution from the hearts were measured at special 
time intervals (flow rate): 
— end of stabilisation phase;
— 5, 10, 15, 20, 25 and 30 min of ischaemia phase;
— 5, 10, 15, 20, 25, 30, 45, 60, 90 and 120 min of 
reperfusion phase.
Lactate levels measurement 
The perfused KHB solutions from the hearts were 
collected in microtubes at the end of stabilisation 
period, 30 min of ischaemia phase and the first 
30 min of reperfusion period. The lactate levels of 
these samples (the marker of the anaerobic glycolysis) 
were measured with lab assays [15, 20].
Infarct size and staining protocol 
In regional ischaemia double staining strategy 
(Evans blue and TTC, respectively) is performed.
After tying secure knots and occluding LAD coro-
nary arteries, the hearts were separated from the 
Langendorff apparatus and Evans blue (0.25% in 
saline) was infused into the hearts via cannula. The 
non-risk zone areas became dark blue and the risk 
zone areas stayed pale pink. Following the freezing 
of the hearts, TTC staining was applied which the 
viable myocytes absorbed the dye and became brick-
red but the non-viable myocardium cells got the pale 
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appearances [3]. The risk zone areas and infarct sizes 
were measured by equations below: 
— Risk zone area (%) = (non-perfused area) / (total 
area of the heart) × 100;
— Infarct size (%) = (dead cells area) / (non-perfused 
area) × 100.
Enumeration of arrhythmias 
By a latex balloon connected to pressure transducer 
in the left ventricle, the normal rhythm of the hearts and 
the irregular heartbeats (single, salvo, triplet, ventricular 
tachycardia [VT] and ventricular fibrillation [VF]) were 
recorded. The arrhythmias were studied by the Lambeth 
Law. The irregular heartbeats are shown in Figure 1.
Statistical analysis 
The results of infarct sizes, haemodynamic parame - 
ters and lactate concentrations in different groups 
were analysed by one-way ANOVA and presented 
as mean ± standard error of the mean (SEM). The 
results of total ventricular ectopic beats (VEBs) which 
is the sum of (single, salvo, triplet and VT) and the 
duration of VT and reversible VF in ischaemia and the 
first 30 min of reperfusion phase were analysed by 
non-parametric Mann-Whitney U-test and expressed 
in mean ± SEM in different groups.
For statistical comparison, the incidence of VT and 
VF results in different groups are analysed by Fisher’s 
exact test and expressed in percent. 
The analysis of all data was done by SPSS Statistics 
17.0 software.
RESULTS
DPPH radical scavenging assay 
The radical scavenging activity of aqueous fraction 
of M. vulgare extract was determined by DPPH assay. 
According to the results, the RC50 value for aqueous 
fraction and quercetin were determined as 47 µg/mL 
and 3.2 µg/mL, respectively.
Total phenolic content assay 
The total phenolic content was determined from 
the standard curve via the equation below:
— Absorbance = 0.0063 × gallic acid (µg) + 0.0372, 
(R2 = 0.999);
— The total phenolic content of the plant aqueous 
extract was equivalent to 6.05 g of gallic acid per 
100 g dry plant material.
Total flavonoids content assay 
The assay was done by colorimetric aluminium 
chloride method and the absorbance of the plant 
extract was calculated from the equation of the stand-
ard curve which is shown below:
— Absorbance = 0.0088 × quercetin (µg) – 0.0625, 
(R2 = 0.9965);
— The total flavonoids content of the plant aqueous 
extract was equivalent to 36.13 mg of quercetin 
per 100 g dry plant material.
Nitric oxide radical inhibition assay 
According to the obtained data, no inhibitory 
activity for nitric oxide radicals by M. vulgare aqueous 
fraction was detected.
TLC analysis
Following the TLC of the extract the Rf value of 
acteoside was calculated as 0.62 which was consistent 
with Rf of standard acteoside.
Figure 1. Arrhythmia’s rhythm. From the top to the bottom: normal 
rhythm, Single ectopic beat, salvos ectopic beats, triplet ectopic 
beat, ventricular tachycardia and ventricular fibrillation.
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Qualitative Stiasny assay 
Following this assay, a brick-red colour precipita-
tion revealed the presence of catechins in the aqueous 
fraction of M. vulgare hydroalcoholic extract.
The effects of aqueous extract of M. vulgare  
on the ischaemic and the first 30 min  
of reperfusion phase arrhythmias 
The effects of aqueous extract of M. vulgare on the 
ischaemic and the first 30 min of reperfusion phase 
arrhythmias are shown in Table 1.
As shown in Table 1, the aqueous extract sig-
nificantly decreased the total VEBs during ischaemic 
phase at all three doses (10, 20 and 40 µg/mL) and 
also considerably reduced the VT duration at the 
doses of 20 µg/mL and 40 µg/mL. No VF was shown 
in the ischaemic period in treated groups.
The effects of the extract on arrhythmias that ap-
peared during the first 30 min of reperfusion phase 
are shown in Table 2.
According to the table, the extract decreased 
the total VEBs with 40 µg/mL significantly. Al-
though the doses of 10 µg/mL and 20 µg/mL de-
creased the total VEBs but the effects were not 
significant. No VT was seen in reperfusion phase 
in the groups which treated by 10 µg/mL and 
40 µg/mL and there was also no occurrence of VF 
in all three treated groups.
Table 2. Effects of Marrubium vulgare aqueous fraction (10, 20 and 40 µg/mL) on ischaemia-reperfusion (I/R)-induced cardiac  
arrhythmias during the first 30 min of reperfusion phase
Ischaemic  
phase
Number Duration [s] Incidence [%]
Single Salvo Triplet VT VEBs VT VF VT VF
Control 64 ± 9.7 6.2 ± 1.4 0.6 ± 0.4 2 ± 2 72.8 ± 10.4 0.4 ± 0.4 5 ± 5 0 25
M. vulgare ext. 
10 µg/mL
37.6 ± 10.1 1.4 ± 0.7* 0.4 ± 0.4 0 39.2 ± 9.9 0 0 0 0
M. vulgare ext. 
20 µg/mL
47.4 ± 7.5 1.6 ± 1.2* 0.4 ± 0.2 2 ± 2 51.4 ± 8.9 0.3 ± 0.3 0 20 0
M. vulgare ext. 
40 µg/mL
36.7 ± 4.8* 2.5 ± 0.5* 0.3 ± 0.3 0 39.5 ± 4.8* 0 0 0 0
*p < 0.05 vs. the control group; n = 6 in each group; VEBs — ventricular ectopic beats (single + salvo + triplet + VT); VT — ventricular tachycardia; VF — ventricular fibrillation
Table 3. The effects of Marrubium vulgare aqueous extract (10, 20 and 40 µg/mL) on the ischaemia-reperfusion (I/R)-induced infarct 
size in isolated rat hearts






Infarct size (%) 50.58 ± 1.23 54.21 ± 5.81 44.57 ± 3.23 15.61 ± 1.29***
***p < 0.001 vs. the control group; n = 6 in each group
Table 1. Effects of Marrubium vulgare aqueous fraction (10, 20 and 40 µg/mL) on ischaemia-reperfusion (I/R)-induced cardiac  
arrhythmias during 30 of min ischaemic phase
Ischaemic 
phase
Number Duration [s] Incidence [%]
Single Salvo Triplet VT VEBs VT VF VT VF
Control 458.3 ± 26.9 77.5 ± 11.9 25.3 ± 5.3 398.3 ± 141.7 959.3 ± 161 56.6 ± 21.9 5.3 100 25
M. vulgare ext. 
10 µg/mL
231 ± 7.6* 14.8 ± 3.7* 2.4 ± 1.1* 125.3 ± 19.4 350.2 ± 25.8* 24.5 ± 4 0 100 0
M. vulgare ext. 
20 µg/mL
83.7 ± 6.4* 7.3 ± 1.9* 2.5 ± 0.8* 46.5 ± 11* 140 ± 8.8* 9 ± 2.2* 0 100 0
M. vulgare ext. 
40 µg/ mL
79.5 ± 9.1* 7 ± 2.1* 3.3 ± 1.3* 53.3 ± 4.5* 143 ± 14.1* 9.9 ± 0.9* 0 100 0
*p < 0.05 vs. the control group; n = 6 in each group; VEBs — ventricular ectopic beats (single + salvo + triplet + VT); VT — ventricular tachycardia; VF — ventricular fibrillation
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The effect of aqueous extract of M. vulgare  
on flow rate parameter during I/R  
Figure 3 is representing the result of flow rate 
during the whole period of experiment. By ligation of 
coronary artery at the end of stabilisation phase, the 
flow rate decreased from 100% to 70 ± 0.05% during 
30 min of ischaemia in control group. By reperfusion, 
the flow rate elevated again to 86 ± 0.06% and then 
gradually decreased to 37 ± 0.05% during 120 min 
of reperfusion phase. The extract at all three doses 
(especially 40 µg/mL) caused a great decline in flow 
rate in 30 min of ischaemia as compared to control 
group. In 120 min of reperfusion period, the flow 
rates in all treated groups were higher than control 
group, but no significant changes were occurred.
The considerable changes of flow rate in control 
and treated groups are shown in Figure 3 by p values 
(**p < 0.01, *p < 0.05).
The effect of aqueous extract of M. vulgare  
on heart rate parameter during I/R  
Figure 4 is showing the result of HR during the 
whole period of experiment. By the ischaemia in-
duction, the HR decreased from 97 ± 0.01% to 
76 ± 0.06% in control group. By reperfusion, the HR 
increased up to 84 ± 0.05% and gradually decreased 
to 67 ± 0.04% during 120 min of reperfusion phase. 
Among all three doses of aqueous extract of M. vul-
gare, only the dose of 40 µg/mL decreased the HR 
during the both ischaemia and the reperfusion phases 
as compared to control group. Hence the aqueous 
extract induced bradycardia but not significantly.
The effect of aqueous extract of M. vulgare  
on infarct size  
Regarding Table 3 and Figure 2, the M. vulgare 
aqueous extract decreased infarct size at the doses 
of 20 µg/mL and 40 µg/mL. The reduction with 
dose of 40 µg/mL was striking and significant 
(***p < 0.001).
Figure 2. The samples of sliced hearts after double staining. From 
the top to the bottom: Control group, ext. 10 µg/mL, ext. 20 µg/mL 
and ext. 40 µg/mL of Marrubium vulgare aqueous extract. Non-risk 
zone areas are dark blue. Viable myocytes are brick-red. Non-viable 
myocardium cells are pale.
Figure 3. Flow rate in the control and treated groups receiving 10, 20 and 40 µg/mL of Marrubium vulgare aqueous fraction during whole  
experiment period. Data are normalised to 15 Stab and represented as mean ± standard error of the mean (SEM); Stab — stabilisation;  
Isc — ischaemia; Rep — reperfusion; Ext — extract; n = 6 rats in each group; **p < 0.01, *p < 0.05.
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The considerable changes of HR in control and 
treated groups are shown in Figure 4 by p values 
(**p < 0.01, *p < 0.05).
The effect of aqueous extract of M. vulgare 
on develop pressure parameter during I/R
Figure 5 is demonstrating the result of DP during 
the whole period of experiment. By commencing 
the ischaemic phase, the DP started decreasing from 
100% to 82 ± 0.08% during 30 min of ischaemia in 
control group. By reperfusion, the DP increased up 
to 85 ± 0.17% and then continuously decreased to 
52 ± 0.05% during 120 min of reperfusion phase. 
The Figure 5 clearly show that the treated group 
with 40 µg/mL indicated the lower DP than control 
group in 30 min of ischaemia. On the contrary, the 
DP increased much more than control group in 
120 min of reperfusion period.
The DP rhythm at doses of 10 µg/mL and 20 µg/mL 
in ischaemic phase were not regular but after reperfu-
sion the DP of these both treated groups increased 
much more than control group especially with 
10 µg/mL of the extract (p < 0.001). The consider-
able changes of DP in control and treated groups are 
Figure 5. Develop pressure in the control and treated groups receiving 10, 20 and 40 µg/mL of Marrubium vulgare aqueous fraction during 
whole experiment period. Data are normalised to 15 Stab and represented as mean ± standard error of the mean (SEM). Stab — stabilisation;  
Isc — ischaemia; Rep — reperfusion; Ext — extract; n = 6 rats in each group; *p < 0.05, **p < 0.01, ***p < 0.001.
Figure 4. Heart rate in the control and treated groups receiving 10, 20 and 40 µg/mL of Marrubium vulgare aqueous fraction during whole 
experiment period. Data are normalised to 15 Stab and represented as mean ± standard error of the mean (SEM); Stab — stabilisation;  
Isc — ischaemia; Rep — reperfusion; Ext — extract; n = 6 rats in each group; **p < 0.01, *p < 0.05.
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Table 4. Lactate concentration (mg/dL) in perfusate at the end of the 30 min of regional ischaemia and during the first 30 min of  
reperfusion phase in the control and treated groups receiving 10, 20 and 40 µg/ml of Marrubium vulgare aqueous extract
Groups Lactate concentration [mg/dL] 
At the end of ischaemia
Lactate concentration [mg/dL] 
30 min after reperfusion
Control + I/R 2.37 ± 0.4375 3.0220 ± 0.28537
Normal control 0.7050 ± 0.15842 0.7050 ± 0.15842
M. vulgare extract (10 µg/mL) 2.18 ± 0.3414 1.9750 ± 0.2335**
M. vulgare extract (20 µg/mL) 2.0216 ± 0.2099 1.6420 ± 0.20346**
M. vulgare extract (40 µg/mL) 2.4433 ± 0.3960 2.608 ± 0.2929
**p < 0.001 vs. control group; IR — ischaemia-reperfusion
shown in Figure 5 by p values (*p < 0.05, **p < 0.01, 
***p < 0.001).
Concentration of lactate in perfusate 
Aqueous extract of M. vulgare did not exert 
considerable positive effect on lactate (a marker 
of anaerobic metabolism) concentration in per-
fusate during ischaemia phase (Table 4). Accord-
ing to Table 4 the extract significantly decreased 
lactate level in perfusate at the dose of 10 µg/mL 
and 20 µg/mL in the first 30 min of reperfusion 
period in comparison to the control + I/R group 
(**p < 0.01).
DISCUSSION 
Since cardiovascular disorders are still one of the 
leading cause of death all over the world especially 
in industrial countries, in recent years, using herbal 
medicines has drawn attention of many researches. 
The important and definite roles of ROS in the 
initiate and progress of heart disorders have been 
reported in several investigations [28]. In ischaemia 
by cessation of blood flow, the aerobic metabolism 
stops and the anaerobic metabolism begins. This 
kind of metabolism makes a decline in intracellular 
pH which leads to ionic derangement. By sudden 
restoration of blood flow to the ischaemic myocar-
dium, the situation becomes worse due to the ROS 
production in the great amounts. ROS is reactive 
oxygen species that can directly injure the heart 
tissue by oxidation of lipids, proteins and DNA, on 
the other hand they can induce the inflammatory 
factors [1, 6, 26].
It has been formerly ascertained that there is 
a positive and linear relationship between plants phe-
nolic contents and their antioxidant activity, in which 
higher phenolic content of a plant materials increases 
the antioxidant activity of the plant. According to our 
results, the aqueous fraction of M. vulgare extract 
was found to accumulate the phenolic compounds 
including phenypropanoids (acteoside) and proan-
thocyanins with a distinguished antioxidant activity. 
As far as we know, proanthocyanidins (condensed 
tannins), the water-soluble subclass of the phenolic 
components, are composed of flavanol (Catechin and 
epicatechin) units that are rich in fruits like berries 
[9, 22]. Catechin and epicatechin, the two most studied 
compounds from proanthocyanidins, have been re-
ported to have an impressive protective role on car-
diovascular system. It is believed that their effective-
ness in reducing the risk of myocardial ischaemia, and 
congestive heart failure have apparently been associ-
ated with their antioxidant, anti-inflammatory, and 
vasodilatory activities [12, 14, 16]. Owing to the fact 
that condensed tannins scavenge the free hydroxyl 
and superoxide radicals, they could prevent cardio-
myocytes and myocardium against oxidative stress, 
reduce reperfusion-induced VF and VT, and increase 
mitochondrial and respiratory chain enzymes (aerobic 
metabolism induction) as well [7, 11, 17, 22, 29]. In 
addition, Jing et al. [13] showed the protective effect 
of acteoside on lipopolysaccharide-induced inflam-
mation in acute lung injury. They demonstrated that 
acteoside increased superoxide dismutase (SOD) and 
inhibited malondialdehyde (MDA) content and levels 
of proinflammatory cytokines in LPS-stimulated mice. 
Previously, we reported the cardioprotective effect of 
methanolic extract of M. vulgare in isoproterenol-
induced myocardial infarction in rats. In that study 
it was found that the extract was rich in non-polar 
secondary metabolites of the plant and marrubiin 
identified as the main active component [27]. 
In current study, we evaluated the protective activ-
ity of aqueous extract of M. vulgare on I/R injuries in 
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the isolated rat heart along with its antioxidant activity. 
The phytochemical screening of the aqueous extract 
showed the presence of acteoside and proanthocya-
nidins. Based on our findings, the aqueous extract 
of M. vulgare markedly lowered infarct size, and the 
total VEBs in ischaemia period. Also arrhythmias were 
decreased in reperfusion phase. These observations 
point to the protective role of the M. vulgare aque-
ous extract in I/R injury. Considering the fact that ROS 
bursts caused by I/R injury result in further destruc-
tive reactions and defective cell functions, it seems 
the protective activity of the M. vulgare extract to be 
partly related to the free radical scavenging activity 
of the phenolics content of the extract. Moreover, the 
simultaneous presence of proanthocyanidins and ac-
teoside may be exerts an additive or synergistic effect 
in protection activity of the extract.
CONCLUSIONS
Overall, Marrubium vulgare aqueous extract signify-
ing to have medicinally valuable secondary metabolites 
and exhibited remarkable effects on different cardiac 
parameters. In general, the present study showed this 
plant has the potential to be protective against cardiac 
complications such as I/R injuries. However, further rig-
orous research is necessary to support the beneficial 
impact of M. vulgare in preventing and/or improving I/R 
injuries and related risk factors. In addition, assessment 
of the possible toxicity of the plant extract is requisite to 
recommend the plant for clinical experiments.
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